Crown Bioscience
Industry / private company
Location:
Leiden,
Netherlands (NL)
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease (2023)
Dagorn PG, Buchholz B, Kraus A, Batchuluun B, Bange H, Blockken L, Steinberg GR, et al.
Journal article
PRECLINICAL EFFICACY OF DIRECT AMPK ACTIVATION WITH A NOVEL SMALL MOLECULE-PXL770-FOR THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2022)
Dagorn PG, Buchholz B, Bange H, Blockken L, Moller DE, Hallakou-Bozec S
Conference contribution